• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-1β通过激活蛋白酪氨酸激酶上调血管内皮生长因子及其受体KDR/flk-1在心脏中的表达。

Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.

作者信息

Maruyama K, Mori Y, Murasawa S, Masaki H, Takahashi N, Tsutusmi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Shibuya M, Inada M, Matsubara H, Iwasaka T

机构信息

Department of Medicine II, Kansai Medical University, Osaka, Japan.

出版信息

J Mol Cell Cardiol. 1999 Mar;31(3):607-17. doi: 10.1006/jmcc.1998.0895.

DOI:10.1006/jmcc.1998.0895
PMID:10198191
Abstract

Vascular endothelial growth factor (VEGF) is not only an endothelial cell-specific angiogenic factor but also a potent mediator of vascular permeability. Interleukin-1 beta (IL-1 beta) is a pro-inflammatory cytokine that has numerous effects on the pathogenesis of the tissue injury. To explore the possible regulation of the VEGF system by IL-1 beta in the heart, we examined the regulation of expression of VEGF and KDR/flk-1 (one of the VEGF receptors) by IL-1 beta using cardiac myocytes and cardiac microvascular endothelial cells (CMEC). Both cardiac myocytes and CMEC substantially expressed VEGF mRNA and its expression was increased 3.6- and 2.4-fold by IL-1 beta, respectively. IL-1 beta-induced accumulations of VEGF mRNA in cardiac myocytes were abolished by the tyrosine kinase inhibitor genistein, whereas inhibition of protein kinase C (PKC) by staurosporin, calphostin C and phorbol ester-induced PKC depletion, and intracellular Ca2+ chelators did not affect the induction of VEGF mRNA by IL-1 beta. Relatively smaller amounts of KDR/flk-1 mRNA were detected in CMEC, but not in cardiac myocytes, and the analysis using quantitative reverse transcription-polymerase chain reaction revealed that IL-1 beta significantly stimulated the accumulation of KDR/flk-1 mRNA 3.0-fold. VEGF protein (23 kDa) levels in Western blot analysis were increased 4.2- and 3.4-fold by IL-1 beta in cardiac myocytes and CMEC, respectively. KDR/flk-1 protein (230 kDa) levels in CMEC were also increased 3.2-fold by IL-1 beta. In addition, pre-treatment of CMEC by IL-1 beta markedly enhanced VEGF-induced tyrosine phosphorylation of focal adhesion kinase compared with that in the unstimulated cells. These findings indicate that cardiac VEGF-KDR/flk-1 system is upregulated by IL-1 beta via activation of tyrosine kinases, suggesting that the IL-1 beta-modulated autocrine and/or paracrine system of VEGF has an important role in the process of angiogenesis in ischemic hearts.

摘要

血管内皮生长因子(VEGF)不仅是一种内皮细胞特异性血管生成因子,也是血管通透性的强效介质。白细胞介素-1β(IL-1β)是一种促炎细胞因子,对组织损伤的发病机制有多种影响。为了探讨IL-1β在心脏中对VEGF系统的可能调节作用,我们使用心肌细胞和心脏微血管内皮细胞(CMEC)研究了IL-1β对VEGF和KDR/flk-1(VEGF受体之一)表达的调节。心肌细胞和CMEC均大量表达VEGF mRNA,其表达分别被IL-1β增加了3.6倍和2.4倍。酪氨酸激酶抑制剂金雀异黄素消除了IL-1β诱导的心肌细胞中VEGF mRNA的积累,而星形孢菌素、钙泊三醇对蛋白激酶C(PKC)的抑制、佛波酯诱导的PKC耗竭以及细胞内Ca2+螯合剂均不影响IL-1β对VEGF mRNA的诱导。在CMEC中检测到相对少量的KDR/flk-1 mRNA,但在心肌细胞中未检测到,定量逆转录-聚合酶链反应分析表明,IL-1β显著刺激KDR/flk-1 mRNA积累3.0倍。蛋白质印迹分析中,IL-1β使心肌细胞和CMEC中的VEGF蛋白(23 kDa)水平分别增加了4.2倍和3.4倍。IL-1β也使CMEC中的KDR/flk-1蛋白(230 kDa)水平增加了3.2倍。此外,与未刺激的细胞相比,IL-1β预处理CMEC显著增强了VEGF诱导的粘着斑激酶酪氨酸磷酸化。这些发现表明,心脏VEGF-KDR/flk-1系统通过酪氨酸激酶的激活被IL-1β上调,提示IL-1β调节的VEGF自分泌和/或旁分泌系统在缺血性心脏血管生成过程中起重要作用。

相似文献

1
Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.白细胞介素-1β通过激活蛋白酪氨酸激酶上调血管内皮生长因子及其受体KDR/flk-1在心脏中的表达。
J Mol Cell Cardiol. 1999 Mar;31(3):607-17. doi: 10.1006/jmcc.1998.0895.
2
Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.缺氧通过视网膜毛细血管内皮细胞中的腺苷A2受体调节血管内皮生长因子受体KDR/Flk基因的表达。
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1311-21.
3
Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.血管通透性因子/血管内皮生长因子介导的小鼠肠系膜血管内皮细胞信号传导
Cancer Res. 1998 Mar 15;58(6):1278-84.
4
Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes.血管内皮生长因子可诱导培养的大鼠心肌细胞中粘着斑激酶(p125FAK)的激活和亚细胞易位。
Circ Res. 1999 May 28;84(10):1194-202. doi: 10.1161/01.res.84.10.1194.
5
Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.SU5416抑制血管内皮生长因子相关酪氨酸激酶活性可阻断微血管内皮细胞球体血管生成模型中的血管芽生。
Microvasc Res. 2002 May;63(3):304-15. doi: 10.1006/mvre.2001.2383.
6
Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.凝血酶诱导牛动脉内皮细胞中KDR表达:一氧化氮的作用
J Cell Physiol. 2002 Feb;190(2):238-50. doi: 10.1002/jcp.10059.
7
The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.类风湿性关节炎和骨关节炎中的血管生成途径“血管内皮生长因子/flk-1(KDR)受体”
J Pathol. 2001 May;194(1):101-8. doi: 10.1002/path.842.
8
A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.一种源自FLT酪氨酸激酶(血管内皮生长因子VEGF的受体)的独特信号转导。
Oncogene. 1995 Jan 5;10(1):135-47.
9
Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.血管内皮生长因子(VEGF)对神经纤毛蛋白-1的选择性诱导:一种促进VEGF诱导血管生成的机制。
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):383-8. doi: 10.1073/pnas.012074399. Epub 2001 Dec 26.
10
Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia.体外循环和心脏停搏后心肌血管内皮生长因子的表达
Circulation. 1998 Nov 10;98(19 Suppl):II242-6; discussion II247-8.

引用本文的文献

1
Perfluoroalkyl substances (PFAS) exposure and preeclampsia risk: Impaired angiogenesis through suppression of VEGF signaling.全氟烷基物质(PFAS)暴露与子痫前期风险:通过抑制VEGF信号传导导致血管生成受损。
Reprod Toxicol. 2025 Mar;132:108827. doi: 10.1016/j.reprotox.2024.108827. Epub 2024 Dec 26.
2
Gene therapy with Pellino-1 improves perfusion and decreases tissue loss in Flk-1 heterozygous mice but fails in MAPKAP Kinase-2 knockout murine hind limb ischemia model.Pellino-1 基因治疗改善 Flk-1 杂合子小鼠的灌注并减少组织损失,但在 MAPKAP Kinase-2 敲除小鼠后肢缺血模型中失败。
Microvasc Res. 2022 May;141:104311. doi: 10.1016/j.mvr.2022.104311. Epub 2022 Jan 7.
3
Inflammatory mediators in diabetic retinopathy: Deriving clinicopathological correlations for potential targeted therapy.
糖尿病性视网膜病变中的炎症介质:为潜在靶向治疗推导出临床病理相关性。
Indian J Ophthalmol. 2021 Nov;69(11):3035-3049. doi: 10.4103/ijo.IJO_1326_21.
4
IL-1β Promotes Vasculogenic Mimicry of Breast Cancer Cells Through p38/MAPK and PI3K/Akt Signaling Pathways.白细胞介素-1β通过p38/丝裂原活化蛋白激酶和磷脂酰肌醇-3激酶/蛋白激酶B信号通路促进乳腺癌细胞的血管生成拟态
Front Oncol. 2021 May 14;11:618839. doi: 10.3389/fonc.2021.618839. eCollection 2021.
5
Mesenchymal stem cells treatment improves vascularization, muscle contraction and VEGF expression, and reduces apoptosis in rat ischemic hind limb.间质干细胞治疗可改善血管生成、肌肉收缩和 VEGF 表达,并减少大鼠缺血后肢的细胞凋亡。
Biochem Pharmacol. 2021 Aug;190:114530. doi: 10.1016/j.bcp.2021.114530. Epub 2021 Apr 21.
6
Cardiotoxic effects of angiogenesis inhibitors.血管生成抑制剂的心脏毒性作用。
Clin Sci (Lond). 2021 Jan 15;135(1):71-100. doi: 10.1042/CS20200305.
7
IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis.IL-1 家族细胞因子对血管通透性和血管生成的调节。
Front Immunol. 2019 Jun 25;10:1426. doi: 10.3389/fimmu.2019.01426. eCollection 2019.
8
The role of inflammation in diabetic eye disease.炎症在糖尿病眼病中的作用。
Semin Immunopathol. 2019 Jul;41(4):427-445. doi: 10.1007/s00281-019-00750-7. Epub 2019 Jun 7.
9
The Long-Term Outcome Comparison of Different Time-Delayed Kallikrein Treatments in a Mouse Cerebral Ischemic Model.小鼠脑缺血模型中不同时间延迟激肽释放酶治疗的长期结果比较
Stem Cells Int. 2018 Apr 5;2018:1706982. doi: 10.1155/2018/1706982. eCollection 2018.
10
The Impact of Pazopanib on the Cardiovascular System.帕唑帕尼对心血管系统的影响。
J Cardiovasc Pharmacol Ther. 2018 Sep;23(5):387-398. doi: 10.1177/1074248418769612. Epub 2018 Apr 29.